Clinical Trials Directory

Trials / Terminated

TerminatedNCT02509377

Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
St. Louis University · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Inclusion and exclusion criteria for fetal repair of MMC was established by the Management of Myelomeningocele Study (MOMS Trial) and these criteria are the standard of care throughout the United States. These criteria state exclusion for hypertension and diabetes which are known co-morbidities for obesity. Investigators plan to expand one exclusion criteria for open fetal repair surgery. Currently, an exclusion factor is a maternal BMI of 35.0 and greater.Investigators will maintain all other inclusion and exclusion criteria (including excluding for hypertension and diabetes) with the exception of expanding the BMI to include mothers with a BMI of 35.0 to 40.0. Co-morbidities of the research group will be compared to the comorbidities of the mothers published in the MOMS trial.

Detailed description

The MOMS trial proved prenatal repair of myelomeningocele was an advantage over postnatal repair for the fetus/neonate/child and is the standard of care for maternal/fetal dyads who meet the inclusion exclusion criteria. Investigators plan to maintain all inclusion exclusion criteria for open fetal repair surgery of myelomeningocele with one exception, the expansion of the maternal BMI to 40.0. This population of mothers with a BMI of 35.0 to 40.0 have not been studied. The morbidities of these mothers will be compared to morbidities of mothers with a BMI less than or equal to 34.9 currently in the scientific literature.

Conditions

Interventions

TypeNameDescription
PROCEDUREOpen Fetal Repair of MyelomeningoceleOpen Fetal Repair of Myelomeningocele when mothers BMI is elevated

Timeline

Start date
2015-07-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2015-07-28
Last updated
2018-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02509377. Inclusion in this directory is not an endorsement.